Status:
COMPLETED
Biomarkers in Bone Marrow and Blood Samples From Older Patients With Acute Myeloid Leukemia Treated With Cytarabine-Based Therapy
Lead Sponsor:
ECOG-ACRIN Cancer Research Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Leukemia
Eligibility:
All Genders
60-120 years
Brief Summary
RATIONALE: Studying samples of bone marrow and blood from patients with cancer in the laboratory may help doctors predict how well patients will respond to treatment. PURPOSE: This research study is ...
Detailed Description
OBJECTIVES: Primary * To validate a pre-specified proteomic classifier to predict the likelihood of complete response (CR) to cytarabine-based induction chemotherapy in older patients with non-M3 ac...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Treated on EST-1490, E-3993, or ECOG-E3999
- Bone marrow and peripheral blood samples collected at diagnosis and before induction chemotherapy available
- No M3 disease
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
July 8 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 8 2010
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01169363
Start Date
July 8 2010
End Date
August 8 2010
Last Update
May 17 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.